Barclays analyst Saket Kalia raised the firm’s price target on Alkami to $27 from $26 and keeps an Equal Weight rating on the shares. The analyst says the company’s annual recurring revenue was better than estimates.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ALKT:
